When did Parabilis Medicines Inc go public?

Parabilis Medicines Inc completed its IPO on Jun 10, 2026 on NASDAQ Global Select under the ticker PBLS and now trades publicly.

What was Parabilis Medicines Inc's IPO price?

Parabilis Medicines Inc priced its IPO at $20.00 per share.

Can I buy Parabilis Medicines Inc stock?

Yes — Parabilis Medicines Inc is publicly traded on NASDAQ Global Select as PBLS. You can follow its live price, valuation and post-IPO performance above.

What is Parabilis Medicines Inc's valuation?

Parabilis Medicines Inc's most recent valuation tracked here is $4.23B, derived from live market prices.

All companies

Parabilis Medicines Inc

PBLS

Public

PublicUnited States(NASDAQ Global Select)Best valuation $4.23BSince IPO +77.90%1 market

Public listing

Listed· NASDAQ Global Select· Listing market: United States

Listing date

Jun 10, 2026

Final IPO price

$20.00

Shares offered

33,500,000

Offering proceeds

$670M

Sources: lifecycle-news, sec-harvest, nasdaq

IPO Calendar · NASDAQIPO

PBLS

Price

$35.58

24h

+1.95%

Valuation

$4.23B

24h volume

$9.38M

Type

IPO

Trade Parabilis Medicines Inc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 2h ago

Parabilis Medicines Inc IPO public float & lock-up

Public float and locked shares extracted from Parabilis Medicines Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4Jun 10, 2026

Total shares (FD)

1.58M

Public float

33.5M

Locked

-31.92M

IPO raise

$670M

Next unlock

—

Needs review: Could not extract a detailed lock-up release schedule.

About Parabilis Medicines Inc

Parabilis Medicines Inc is an operating company with a business profile centered on its products, services, customers, and execution strategy.

What the company does

Operates with a business profile defined by its products, services, customers, and operating execution.
Its durable fundamentals depend on demand for its products or services, margin structure, competitive position, management execution, and capital discipline.
Primary company filings and official materials are the best source for detailed information about revenue drivers, risk factors, and operating strategy.

Business profile

Parabilis Medicines Inc should be evaluated through its durable business model: what it sells, who it serves, how it generates revenue, and how efficiently it can scale.

SEC IPO filings

Final prospectus

EDGAR filings resolved from PBLS / CIK 0001657677.

424B4424B4

Jun 10, 2026Final prospectus0001193125-26-265983

FWPFWP

Jun 10, 2026Free writing prospectus0001193125-26-264521

EFFECTxslEFFECTX01/primary_doc.xml

Jun 9, 2026Effective9999999995-26-001929

CERT8A_Cert_PBLS_0001657677.pdf

Jun 9, 2026Exchange registration0001354457-26-000549

S-1/AS-1/A

Jun 9, 2026Amended0001193125-26-262880

8-A12B8-A12B

Jun 5, 2026Exchange registration0001193125-26-259552

S-1/AS-1/A

Jun 4, 2026Amended0001193125-26-256398

S-1/AS-1/A

May 27, 2026Amended0001193125-26-242067

S-1S-1

May 19, 2026Filed0001193125-26-230994

DRSfilename1.htm

Apr 2, 2026Confidential draft0001193125-26-140488

Parabilis Medicines Inc IPO — frequently asked questions

When did Parabilis Medicines Inc go public?: Parabilis Medicines Inc completed its IPO on Jun 10, 2026 on NASDAQ Global Select under the ticker PBLS and now trades publicly.
What was Parabilis Medicines Inc's IPO price?: Parabilis Medicines Inc priced its IPO at $20.00 per share.
Can I buy Parabilis Medicines Inc stock?: Yes — Parabilis Medicines Inc is publicly traded on NASDAQ Global Select as PBLS. You can follow its live price, valuation and post-IPO performance above.
What is Parabilis Medicines Inc's valuation?: Parabilis Medicines Inc's most recent valuation tracked here is $4.23B, derived from live market prices.